Effects of four Chinese herbal extracts on drug-sensitive and multidrug-resistant small-cell lung carcinoma cells David SadavaJulie AhnSusan E. Kane Original Article Pages: 261 - 266
Dihydropyrimidine dehydrogenase expression in preoperative biopsy and surgically resected specimens of gastric carcinoma Hiroaki NozawaHajime TsukuiTakayoshi Sekikawa Original Article Pages: 267 - 273
Effects of paclitaxel, cyclophosphamide, ifosfamide, tamoxifen and cyclosporine on the metabolism of methoxymorpholinodoxorubicin in human liver microsomes Dominique Beulz-RichéJacques RobertDamrong Ratanasavanh Original Article Pages: 274 - 280
XK469, a novel antitumor agent, inhibits signaling by the MEK/MAPK signaling pathway Hong LinBalanehru SubramanianBen D. Chen Original Article Pages: 281 - 286
Population pharmacokinetics of the novel anticancer agent KRN7000 Mirjam CrulRon A. MathôtJos H. Beijnen Original Article Pages: 287 - 293
Alterations in intestinal permeability following the intensified polydrug-chemotherapy IFADIC (ifosfamide, Adriamycin, dacarbazine) Barbara Fazeny-DörnerMario VeitlChristine Marosi Original Article Pages: 294 - 298
Lack of activity of stealth liposomal doxorubicin in the treatment of patients with anthracycline-resistant breast cancer Edgardo RiveraVicente ValeroGabriel N. Hortobagyi Original Article Pages: 299 - 302
Low dose–high dose: what is the right dose? Pharmacokinetic modeling of etoposide Gudrun WürthweinJoachim Boos Original Article Pages: 303 - 308
Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study Norman E. SládekRahn KollanderDavid T. Kiang Original Article Pages: 309 - 321
P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel Yoshimitsu KimuraJun AokiOsamu Nakanishi Original Article Pages: 322 - 328
Determinants of the cytotoxicity of irinotecan in two human colorectal tumor cell lines Valérie PavillardCécile AgostiniJacques Robert Original Article Pages: 329 - 335
Biliary transport of irinotecan and metabolites in normal and P-glycoprotein-deficient mice Lalitha IyerJacqueline RamírezUlrich Mayer Original Article Pages: 336 - 341
A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy A. Vis A. van der Gaast G. Mickisch Clinical Trial Report Pages: 342 - 345